These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Mechanism of action and clinical use of ticlopidine]. Kirichenko AA Kardiologiia; 2006; 46(4):75-80. PubMed ID: 16710210 [TBL] [Abstract][Full Text] [Related]
3. Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry. Rubboli A; Palmieri C; Piovaccari G; DI Pasquale G; Briguori C; Margheri M; Panminerva Med; 2016 Sep; 58(3):242-3. PubMed ID: 27377182 [No Abstract] [Full Text] [Related]
4. Antithrombotic therapy in the elderly. Capodanno D; Angiolillo DJ J Am Coll Cardiol; 2010 Nov; 56(21):1683-92. PubMed ID: 21070918 [TBL] [Abstract][Full Text] [Related]
5. Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease. Califf RM; Mark DB Am Heart J; 1997 Nov; 134(5 Pt 2):S88-96. PubMed ID: 9396640 [No Abstract] [Full Text] [Related]
6. CLINICAL AND PHARMACEUTICAL ASPECTS OF THE USE OF ANTITHROMBOTIC DRUGS IN PATIENTS SUFFERING FROM ISCHEMIC HEART DISEASE (REVIEW). Zhunussov Y Georgian Med News; 2016 Feb; (251):32-9. PubMed ID: 27001783 [TBL] [Abstract][Full Text] [Related]
7. Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit? Mahtta D; Virani SS J Med Econ; 2020 Jul; 23(7):670-672. PubMed ID: 32267794 [No Abstract] [Full Text] [Related]
8. Antithrombotic therapy for ischemic cerebrovascular disease. Biller J; Love BB; Gordon DL Semin Neurol; 1991 Dec; 11(4):353-67. PubMed ID: 1811292 [No Abstract] [Full Text] [Related]
9. Antithrombotic therapy in acute ischemic stroke. Dorman P; Counsell C; Sandercock P Arch Intern Med; 1995 Dec 11-25; 155(22):2481. PubMed ID: 7503609 [No Abstract] [Full Text] [Related]
10. [The antithrombotic treatment of acute ischemic stroke: a problem solved?]. Chamorro A Med Clin (Barc); 1998 Dec; 111(19):736-7. PubMed ID: 9922956 [No Abstract] [Full Text] [Related]
11. Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW; Easton JD; Sacco RL; Teal P Chest; 1998 Nov; 114(5 Suppl):683S-698S. PubMed ID: 9822071 [No Abstract] [Full Text] [Related]
12. An overview of antithrombotics in ischemic stroke. Schweickert PA; Gaughen JR; Kreitel EM; Shephard TJ; Solenski NJ; Jensen ME Nurse Pract; 2016 Jun; 41(6):48-55. PubMed ID: 27153001 [TBL] [Abstract][Full Text] [Related]
13. Combining antithrombotic and fibrinolytic agents: can it be done? Khatri P; Mono ML Stroke; 2013 May; 44(5):1489-91. PubMed ID: 23559267 [No Abstract] [Full Text] [Related]
14. Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs. Catella-Lawson F; FitzGerald GA Circulation; 1997 Feb; 95(4):793-5. PubMed ID: 9054731 [No Abstract] [Full Text] [Related]
17. [Antithrombotic therapy in acute coronary syndrome]. Chazov EI; Panchenko EP Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658 [No Abstract] [Full Text] [Related]
18. [Fibrinolytic agents in cerebral ischemic accidents. A hope more reserved than in myocardial infarction]. Orgogozo JM Rev Prat; 1992 Dec; 42(20):2585-7. PubMed ID: 1299945 [No Abstract] [Full Text] [Related]
20. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk. Freudenberger RS; Fuster V Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540 [No Abstract] [Full Text] [Related] [Next] [New Search]